The global laboratory animal model market plays a critical role in advancing biomedical research, drug discovery, and preclinical testing. Laboratory animal models, including mice, rats, rabbits, and other species, are extensively used to study disease mechanisms, evaluate drug efficacy, and ensure safety before human clinical trials. The increasing complexity of diseases, particularly cancer, neurological disorders, and infectious diseases, has significantly boosted the demand for reliable and genetically modified animal models. With continuous innovation in biotechnology and rising investments in pharmaceutical research, the market is evolving rapidly, offering new opportunities for stakeholders across the life sciences industry.
Laboratory Animal Model Market Analysis and Overview
The Laboratory Animal Model Market is expected to register a CAGR of 8.1% during 2025–2031, reflecting steady expansion driven by growing demand in drug discovery and biomedical research. The market growth is primarily fueled by increasing R&D activities in the pharmaceutical and biotechnology sectors, along with the rising prevalence of chronic diseases that require advanced research models. Laboratory animal models remain indispensable for understanding disease progression, testing therapeutics, and supporting regulatory approvals. Furthermore, advancements in gene-editing technologies such as CRISPR and the development of humanized animal models are enhancing research accuracy and efficiency, thereby strengthening the overall market outlook through 2031.
Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00025691
Key Market Drivers and Growth Factors
A major driver of the laboratory animal model market is the increasing demand for drug discovery and development. Pharmaceutical and biotechnology companies rely heavily on animal models to test the safety and effectiveness of new drugs before clinical trials. This demand is further amplified by the growing pipeline of novel therapeutics targeting complex diseases such as cancer, cardiovascular disorders, and neurological conditions.
Another significant growth factor is the rising prevalence of chronic diseases worldwide. Conditions such as diabetes, cancer, and neurodegenerative disorders require extensive research to develop effective treatments. Laboratory animal models provide valuable insights into disease mechanisms, enabling researchers to design targeted therapies and improve patient outcomes.
Advancements in biotechnology and personalized medicine are also contributing to market growth. The increasing use of genetically modified animal models allows researchers to study specific genetic variations and their impact on diseases. This has become particularly important in precision medicine, where treatments are tailored to individual patient profiles.
Emerging Trends in the Laboratory Animal Model Market
The market is witnessing several key trends that are shaping its future trajectory. One of the most prominent trends is the development of genetically engineered animal models. These models, including transgenic and knockout animals, are widely used to study gene functions and disease pathways, enabling more accurate and targeted research outcomes.
Another important trend is the growing adoption of humanized animal models. These models incorporate human genes, tissues, or immune systems, providing more relevant insights into human diseases and improving the predictability of drug responses. This trend is gaining traction in oncology and immunology research.
Additionally, there is a rising emphasis on ethical considerations and alternative research methods. Technologies such as organ-on-a-chip, 3D cell cultures, and in silico modeling are being developed to reduce reliance on animal testing. While these alternatives present challenges to the traditional market, they also encourage innovation and more ethical research practices.
Market Segmentation Insights
The laboratory animal model market is segmented based on animal type, application, and end user. By animal type, the market includes mice, rats, guinea pigs, rabbits, and others. Among these, mice and rats dominate the market due to their genetic similarity to humans and ease of handling in research settings.
In terms of application, the market is categorized into drug discovery and development and basic research. The drug discovery and development segment holds a significant share, driven by the increasing demand for preclinical testing and the growing pharmaceutical pipeline.
Based on end users, the market includes pharmaceutical and biotechnology companies, academic research institutes, and others. Pharmaceutical and biotech companies account for the largest share due to their extensive R&D activities and reliance on animal models for drug development.
Regional Market Insights
Geographically, the laboratory animal model market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America. North America dominates the market, supported by strong research infrastructure, high healthcare expenditure, and the presence of leading pharmaceutical companies.
Europe also holds a significant market share due to robust regulatory frameworks and increasing investment in biomedical research. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth during the forecast period. Factors such as expanding pharmaceutical industries, increasing government funding for research, and rising awareness about advanced healthcare solutions are driving market growth in countries like China and India.
Competitive Landscape and Key Players
The global laboratory animal model market is highly competitive, with several key players focusing on innovation, partnerships, and expansion strategies to strengthen their market presence. Leading companies operating in the market include:
- Charles River Laboratories International, Inc.
- Envigo
- Eurofins Scientific
- genOway
- Hera Biolabs
- JSR Life Sciences, LLC (Crown Bioscience International)
- Ozgene Pty Ltd.
- PerkinElmer (Horizon Discovery Ltd.)
- Taconic Biosciences, Inc.
These companies are actively investing in advanced technologies, including gene editing and humanized models, to enhance their product offerings and meet the evolving needs of the research community.
Future Outlook and Opportunities
The future of the laboratory animal model market appears promising, driven by continuous advancements in biotechnology and increasing demand for innovative research tools. The integration of gene-editing technologies, personalized medicine, and advanced disease modeling techniques is expected to revolutionize the market landscape.
Moreover, growing investments in healthcare research and the expansion of pharmaceutical pipelines are likely to create new growth opportunities. Despite challenges such as ethical concerns and regulatory restrictions, the market is expected to maintain steady growth through 2031.
In conclusion, the global laboratory animal model market is poised for sustained expansion, supported by rising research activities, technological advancements, and increasing demand for effective therapeutic solutions.
Top Trending Reports:
Animal Care Services Market Analysis, Regional and Competitive Landscape Forecast by 2031
Laboratory Equipment Services Market Opportunities, Forecast, Size, Analysis till 2031
Laboratory Developed Test Market Size Trends & Key Opportunities 2034
About Us
The Insight Partners is a leading global market research and consulting firm that provides actionable insights across various industries, including healthcare, life sciences, and technology. Our reports are designed to help organizations make informed decisions by offering comprehensive market analysis, trends, and forecasts.
Contact Us
The Insight Partners
Email: sales@theinsightpartners.com
Phone: +1-646-491-9876
Website: www.theinsightpartners.com
Also Available in: Korean | German | Japanese | French | Chinese | Italian | Spanish
